Krystal Biotech KRYS
NASDAQ KRYS
$322.28 -3.03 (-0.93%)
At close: Oct 2, 2026 · 4:00 PM EDT

Krystal Biotech (KRYS) Cash & Current Investments (2016 - 2026)

Updated

Krystal Biotech (KRYS) reported Cash & Current Investments of $845.63 million for Q2 2026, up 24.0% from $681.99 million a year earlier and up 2.7% from the prior quarter.

Analysis

Krystal Biotech (KRYS) Cash & Current Investments (2016 - 2026) Analysis & Trends

At the end of FY2025, Krystal Biotech posted Cash & Current Investments of $827.79 million, up 38.5% from FY2024.

  • Cash & Current Investments has increased for three consecutive years, with a five-year compound annual growth rate of 25.0% (FY2020 to FY2025).
  • By year, Cash & Current Investments came in at $597.52 million in FY2024 (+12.3%), $532.18 million in FY2023 (+40.4%), $379.17 million in FY2022 (-13.5%) and $438.1 million in FY2021 (+61.5%).
  • The Q2 2026 figure ranks as the highest quarterly Cash & Current Investments in data going back to Q4 2016.
  • Year over year, Cash & Current Investments has now increased in each of the last 13 quarters, with growth averaging 21.7% over the last eight quarters.
  • The high point for year-over-year Cash & Current Investments in five years was Q4 2021 (growth of 61.5%); the low point was Q1 2023 (a decline of 19.4%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $823.41 million (Q1 2026), $827.79 million (Q4 2025) and $731.07 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Krystal Biotech 9.54 Bn 6.31 Bn 112.79 Mn 845.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 845.63 Mn
Mar 31, 2026 823.41 Mn
Dec 31, 2025 827.79 Mn
Sep 30, 2025 731.07 Mn
Jun 30, 2025 681.99 Mn
Mar 31, 2025 616.85 Mn
Dec 31, 2024 597.52 Mn
Sep 30, 2024 588.32 Mn
Jun 30, 2024 559.61 Mn
Mar 31, 2024 538.26 Mn
Dec 31, 2023 532.18 Mn
Sep 30, 2023 562.07 Mn
Jun 30, 2023 477.52 Mn
Mar 31, 2023 350.39 Mn
Dec 31, 2022 379.17 Mn
Sep 30, 2022 394.42 Mn
Jun 30, 2022 425.57 Mn
Mar 31, 2022 434.63 Mn
Dec 31, 2021 438.10 Mn
Sep 30, 2021 343.09 Mn
API Access

Krystal Biotech Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=KRYS&period=max&api_key=YOUR_API_KEY